Clinical Trial Update: A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease [Phase 4]

View source ↗

Summary

A completed Phase 4 study comparing galantamine and donepezil in Alzheimer's disease, assessing effects on sleep, attention, and gastrointestinal tolerance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)
• Galantamine (galantamine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Alzheimer Disease | Phase 4 | Status: COMPLETED